Primetime Profiles

Investors are paying attention to Bionomics Limited (Nasdaq: BNOX) (ASX: BNO). And rightly so, considering the company is on pace to commence two Phase 3 trials to treat critical unmet medical needs. The first to is expected to be for BNOX’s drug candidate to treat Post Traumatic Stress Disorder (PTSD), a logical assumption considering that

Mobilicom Limited (NasdaqCM: MOB) stock is earning investors’ attention. And rightly so. Its stock is higher by over 50% so far in 2023. While an impressive run, the better news for the company and its investors is that those gains could be the precursor to even higher highs. That may sound like overzealous bullish expectations,

Grid Battery Metals Inc. (OTCQB: EVKRF) stock reclaimed its bullish mood, evidenced by its price increase to over $0.103 since last Friday’s close. The potentially better news is that breaching its 52-week highs is a viable near-term target, with the $0.12 level, about 20% higher than the current, in investors’ crosshairs. And keep in mind

Kartoon Studios (NYSE-Amer: TOON) might operate under the radar for many, but certainly not for everyone—analysts included. Among them is an analyst from Dawson James, a reputable Wall Street firm that can hold investors’ attention. Essential to the TOON investment proposition is his coverage of TOON is decidedly bullish. In fact, his research led to